Current Research Studies
Expanded Access Protocol of Apitegromab for Patients With Spinal Muscular Atrophy
Apitegromab EAP
What is the goal of the study?
Provide apitegromab to patients prior to FDA approval.
Who can participate in the study?
Non-ambulatory patients 2 years or older with Spinal Muscular Atrophy